We studied remifentanil and propofol for analgesia and sedation during the placement of an ophthalmic block. Eighty ASA I or II patients undergoing elective cataract surgery under a retrobulbar block in a rural camp setting were included in the study. Patients were randomly divided into four groups and received different drug combinations as follows: Group I-remifentanil 1 µg/kg, Group II-remifentanil 0.5 µg/kg and propofol 0.5 mg/kg, Group IIIremifentanil 1 µg/kg with propofol 0.5 mg/kg and Group IV-saline 0.1 ml/kg. Patients were observed for degree of movement, sedation, pain, recall and respiratory depression.
Cataract surgery in adults is a short procedure often performed under regional nerve block 1 . Although the peribulbar block is presently the most widely practised nerve block in ophthalmic surgery, the retrobulbar nerve block (RBB) is still popular in many hospitals especially in an eye camp setting where an intense block with a quick onset is needed. Eye camps are makeshift facilities organized by mobile teams, designed to provide eye care, particularly cataract surgery, in remote parts of the country and conducted on a "walk in/walk out" basis. The performance of RBB is painful and may be associated with catecholamine mediated sequelae including anxiety, tachycardia and hypertension which may produce considerable morbidity and mortality 2, 3 . Moreover the pain associated with this block may lead to movement during the placement of the block which can increase the risk of complications such as inadequate block, retrobulbar haemorrhage, brainstem anaesthesia and even cardiopulmonary arrest [4] [5] [6] [7] . Therefore, it is desirable to provide analgesia and sedation during the placement of the block. An inadequately sedated patient may be uncooperative and may move during painful stimulation.
The ideal drug for this procedure would then be one which provides complete analgesia yet allows the patient to be awake and cooperative, with no residual sedation which would delay discharge from the hospital 8 . Various drugs alone or in combination have been used to provide sedation during ophthalmic nerve blocks [9] [10] [11] [12] . The introduction of short acting opioids and hypnotics has seen their successful use in providing sedation for this purpose 8, 13, 14 .
Remifentanil is a novel ultra-short-acting opioid which is known for its rapid onset (1-2 min), intense analgesia and extremely short duration of action (context-sensitive half-life of 3-8 min) 15 and is therefore suited for brief painful stimuli 13, 14, 16 . Similarly, propofol is a well accepted and widely used drug for sedation in ophthalmic surgery because of its high clearance and favourable recovery profile [16] [17] [18] [19] .
This prospective, randomized, placebo controlled, single blind study was designed to evaluate the use of remifentanil alone or in combination with propofol prior to the performance of the retrobulbar block for cataract surgery and to study the degree of movement, pain, recall and the incidence of adverse events.
MATERIALS AND METHODS
After approval from the Institutional Ethics Committee, eighty consenting patients (ASA grade 1 or 2) scheduled for elective cataract surgery in a rural eye camp were enrolled in the study. Exclusion criteria were age below 18 years, allergy to any of the study drugs, morbid obesity (more than 100% greater than ideal body weight), chronic use of opioids, or a positive pregnancy test.
Patients were randomly divided into four groups of 20 each. Group I received 1 µg/kg of remifentanil, Group II 0.5 µg/kg of remifentanil with 0.5 mg/kg of propofol, Group III 1 µ/kg of remifentanil with 0.5 mg/kg of propofol, and Group IV 0.1 ml/kg of saline, by intravenous bolus injection just prior to the placement of RBB.
All patients were fasted overnight and did not receive any preanaesthetic medication. On arrival in the operating room intravenous access was established with an 18 gauge cannula. Monitoring consisted of electrocardiography, pulse oximetry and non-invasive blood pressure measurement. A nasal cannula was positioned to deliver 3-4 l/min of oxygen. Baseline measurement of mean arterial pressure, heart rate, respiratory rate and SpO 2 were made. The patients were then administered the respective study drug/s over a period of 60 seconds. Ninety seconds after injecting the drug, the patient's level of sedation was assessed by a blinded investigator using the Observer's Assessment of Alertness/Sedation (OAA/S) scale, modified by reversing the order of the scores (with a composite score of 1=awake and alert to 5=unresponsiveness) 20 (Appendix I). The RBB was then placed by the ophthalmic surgeon. During the performance of the block the degree of movement was graded by the same blinded investigator using a numerical scale as follows: 0=no movement by the patient during block placement; 1=movement that did not interfere with block placement and 2=movement that interfered with block placement.
Similarly the amount of respiratory depression was graded as follows: 0=no detectable respiratory depression; 1=detectable respiratory depression that does not require intervention (defined as >5% decrease in SpO 2 , >20% decrease in respiratory rate and/or clinically detectable airway obstruction); 2= detectable respiratory depression that requires intervention (defined as SpO 2 <90%, Respiratory rate <6 breaths/min or apnoea >20/s) 8 . Haemodynamic variables were measured every minute up to 5 minutes after the block. After the completion of the surgery, patients were asked about the experience of receiving the block, incidence of nausea/vomiting, or recall of receiving the block. Patients who recalled receiving the block were asked to grade the pain, if any, experienced during the block. The pain was graded in a four point verbal rating scale where 0 is no pain and 3 is severe pain.
All data was analysed using the chi-square test or Student's t-test. A P value of <0.05 was considered statistically significant.
RESULTS
The four study groups were similar with respect to demographic and baseline physiologic characteristics (Table 1) .
Pain
No patient experienced any pain in Groups I, II and III where as in Group IV 10 (50%) patients had severe pain, seven (35%) moderate and three (15%) had mild pain (P<0.001).
Movement
No patient showed any movement in Groups I, II and III except one patient in Group III who showed sudden involuntary movement. In Group IV, seven (35%) patients showed grade II movement and nine (45%) patients had grade I movement during the placement of RBB (P<0.001) ( Figure I) have led to failure of block in two patients and retrobulbar haemorrhage in one patient in the placebo group.
Sedation
Most of the patients were conscious and remained responsive to verbal commands and the level of sedation as graded on the OAA/S scale remained between 2 and 3 in the study groups except for four (20%) patients in group III who had a sedation score of 4 (P<0.05) ( Table 2) .
Recall
The incidence of recall, other than control group (100%) was maximum in Group I (55%) and the least in Group III (5%) (Figure 2) .
Haemodynamics
There were no haemodynamic alterations and all patients were completely alert at 5 minutes after the block.
Respiratory depression
Respiratory depression was maximum in Group III where twelve (60%) patients had grade II respiratory depression and four (20%) had grade I respiratory depression (P<0.01). In Group I, four (20%) patients had grade II and three (15%) patients had grade I respiratory depression following the injection of the drug. On the other hand, only one (5%) patient had grade II and five (25%) patients had grade I respiratory depression in Group II ( Table 2 ). Most of the patients who had respiratory depression, experienced transient apnoea with a fall in SpO 2 which was treated rapidly by asking the patient to take deep breaths. One patient in Group III had airway obstruction leading to fall in SpO 2 to <70% and needed ventilation with a bag and mask. This was also associated with rigidity of the extremities. The patient recovered with adequate, spontaneous respiration within three minutes.
Adverse events
The incidence of other adverse events was maximum in Group I where two patients (10%) complained of intraoperative nausea, two patients (10%) had pruritus and one patient had rigidity. No patient in Group II suffered from any adverse event. In Group III, one patient (5%) had nausea and rigidity following the drug.
DISCUSSION
The placement of an ophthalmic block is associated with significant pain and anxiety. Several sedatives and opioids have been used to relieve this pain and anxiety [9] [10] [11] [12] . However, the effect of these drugs extends into the surgical period when a cooperative, conscious patient is needed.
To overcome these problems we evaluated the use of remifentanil alone or in combination with propofol to provide analgesia and sedation for the placement of the block.
Remifentanil has been previously used for the placement of ophthalmologic blocks, both as a bolus and infusion with good results 14, 16 , but for adequate effect, a higher dose of remifentanil needs to be used which leads to an increased incidence of respiratory depression 14 . Moreover, if used alone it does not provide optimal sedation 21 attempted to decrease the dose of remifentanil and use it in combination with propofol. All patients receiving remifentanil had intense analgesia and did not show any movement during the placement of the block. Most of the patients (85%) in the control group complained of significant pain during the administration of the block resulting in possible movement related complications in 15% of these patients.
Patients who received remifentanil alone had a very high incidence of recall (55%) and hence the element of anxiety still remained. The addition of propofol at 0.5 mg/kg helped sedate the patient and minimize recall. In previous studies, propofol has been used in doses of 0.63 and 0.5 mg/kg for successful prevention of recall 18, 22 . Another study showed that a single sub-anaesthetic dose of propofol calculated with the help of a formula based on the weight and height of the patient [56+0.25 x weight (kg) -0.53 x age (y)], effectively abolished recall of the block in 78.6% patients 23 .
Respiratory depression, though transient, was seen in 35% of the patients receiving 1 µg/kg of remifentanil, which is similar to that seen in the study by Ahmad et al 14 . The addition of propofol to 1 µg/kg of remifentanil in Group III led to a very high incidence of significant (grade II) respiratory depression (60%). On the other hand, reducing the dose of remifentanil to 0.5 µg/kg in Group II, reduced the incidence of grade II respiratory depression to 5% only. Thus, the combination of 0.5 µg/kg remifentanil and 0.5 mg/kg propofol provided adequate pain relief and amnesia for the placement of the ophthalmic block with shortlasting sedation. Moreover, there was no delay in discharge from the daycare centre and all patients could go home after six hours of surgery as per the protocol of the eye camp.
We conclude that the combination of 0.5 µg/kg remifentanil and 0.5 mg/kg propofol as a single bolus provides effective analgesia, anxiolysis and sedation for the placement of an ophthalmic block, with a mild risk of transient respiratory depression.
